Art Unit 3681
Group 3680Business Methods: Electronic Shopping and Health Care
- Active examiners
- 45
- Average office actions per grant
- 2.91
Grant ratio
- Art Unit 3681
- 31.9%
- Group 3680
- 38.7%
Active examiners
| Sun Li | 53.9% | 2.70 | August 2026 |
|---|---|---|---|
| Sam Refai | 34.3% | 2.64 | August 2026 |
| Thuy Nguyen | 54.7% | 2.56 | August 2026 |
| Bion A Shelden | 20.7% | 3.96 | August 2026 |
| Christopher Busch | 25.3% | 2.80 | August 2026 |
| Rashida R Shorter | 19.0% | 4.06 | August 2026 |
| Breffni X Baggot | 48.6% | 2.92 | August 2026 |
| Marie P. Brady | 19.1% | 3.05 | June 2026 |
| Alexandru Cirnu | 27.0% | 2.97 | August 2026 |
| Kyle G Robinson | 14.4% | 4.16 | August 2026 |
| Chad A Newton | 10.5% | 3.35 | August 2026 |
| John P Go | 5.4% | 2.83 | August 2026 |
| James M Detweiler | 52.7% | 2.62 | August 2026 |
| Eliza Lam | 12.6% | 3.15 | August 2026 |
| Michael Tomaszewski | 20.0% | 2.03 | August 2026 |
| Sheetal R. Paulson | 18.4% | 3.39 | August 2026 |
| Stella Higgs | 1.4% | 3.06 | August 2026 |
| Alfred H Tsui | 37.9% | 5.07 | August 2026 |
| Affaf Ahmed | 13.3% | 3.00 | August 2026 |
| Jay M Patel | 26.7% | 2.54 | August 2026 |
| Olivia R Gedra | 0.0% | N/A | August 2026 |
| Raquel Alvarez | 80.4% | 3.00 | August 2026 |
| Sara J Morice | 3.6% | 3.00 | August 2026 |
| Rachael Sojin Stone | 9.8% | 2.39 | August 2026 |
| Kimberly Vander Woude | 2.1% | 1.00 | August 2026 |
| Jamie Kucab | 53.3% | 2.91 | August 2026 |
| Chinyere Mpamugo | 42.1% | 3.99 | August 2026 |
| Aaisha Abdullah | 8.1% | 3.60 | August 2026 |
| William T. Monticello | 2.9% | 2.45 | August 2026 |
| Monica A Mandel | 37.0% | 4.70 | July 2026 |
| Peter Choi | 0.0% | 1.98 | August 2026 |
| Matthew L. Hamilton | 0.0% | 2.62 | August 2026 |
| Patricia K Edouard | 0.0% | 3.20 | August 2026 |
| Roger L Pang | 95.0% | 1.42 | August 2026 |
| Alexis K Van Duzer | 5.9% | 1.00 | August 2026 |
| Arthur Duran | 25.0% | 4.28 | August 2026 |
| Richard M. Lorence | 87.5% | 1.38 | August 2026 |
| Tisha D Lewis | 93.8% | 1.43 | August 2026 |
| Edwin A. Young | 100.0% | 1.15 | August 2026 |
| Joseph Burgess | 0.0% | 2.79 | August 2026 |
| Derek D. Knight | 90.9% | 1.37 | August 2026 |
| Michael Ezewoko | 9.1% | 2.46 | August 2026 |
| Sherry Lynn Estremsky | 90.0% | 1.26 | July 2026 |
| Scott Snider | 25.0% | 4.46 | August 2026 |
| Liliana Cerullo | 50.0% | 1.00 | July 2026 |
Examiner distribution
- Median grant ratio
- 19.1%
- Middle 50% of grant ratios
- 6.1%–37.7%
- Median office actions / grant
- 2.97
- Middle 50% of office actions / grant
- 2.62–3.35
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| William A. Brandenburg | 27.8% | 3.51 | July 2020 Appears inactive |
|---|---|---|---|
| Daniel M. Sorkowitz | 16.7% | 4.36 | April 2020 Appears inactive |
| Mario Iosif | 27.1% | 3.78 | December 2025 Appears inactive |
| Michael W Schmucker | 46.3% | 3.19 | January 2025 Appears inactive |
| Rodney M. Henry | 10.9% | 3.83 | May 2022 Appears inactive |
| Daniel Lastra | 94.7% | 2.55 | September 2016 Appears inactive |
| Brendon Beheshti | 0.0% | 3.60 | January 2020 Appears inactive |
| Arthur E. Geldres | 0.0% | N/A | November 2017 Appears inactive |
| David D. Le | 89.7% | 1.24 | November 2014 Appears inactive |
| Rodney H. Bonck | 93.1% | 1.71 | September 2015 Appears inactive |
| Donald L. Champagne | 85.7% | 2.14 | June 2014 Appears inactive |
| Michael Cross | 84.6% | 5.20 | August 2021 Appears inactive |
| Dirk Wright | 95.8% | 1.18 | September 2022 Appears inactive |
| Gregory D Moseley | 21.7% | 4.17 | September 2025 Appears inactive |
| Hajime Rojas | 14.3% | 3.19 | January 2026 Appears inactive |
| Khanh H. Le | 13.3% | 2.15 | September 2014 Appears inactive |
| Ha D. Ho | 100.0% | 1.17 | February 2025 Appears inactive |
| Kelan Michael Burns | 0.0% | N/A | August 2025 Appears inactive |
| Jamisue A. Plucinski | 33.3% | 2.11 | March 2015 Appears inactive |
| Tom Oldakowski | 0.0% | N/A | April 2020 Appears inactive |
| John Ligerakis | 50.0% | 1.25 | January 2009 Appears inactive |
Based on available public USPTO records; may be incomplete.